Home LiteratureArticle Details
PMID: 17517861 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.

Infection and immunity ·Vol. 75 ·No. 8 ·2007-08-00 ·Pages 3941-9

Hagan EC, Mobley HL

Abstract

Uncomplicated urinary tract infection (UTI) caused by uropathogenic Escherichia coli (UPEC) represents a prevalent and potentially severe infectious disease. In this study, we describe the application of an immunoproteomics approach to vaccine development that has been used successfully to identify vaccine targets in other pathogenic bacteria. Outer membranes were isolated from pyelonephritis strain E. coli CFT073 cultured under conditions that mimic the urinary tract environment, including iron limitation, osmotic stress, human urine, and exposure to uroepithelial cells. To identify antigens that elicit a humoral response during experimental UTI, outer membrane proteins were separated by two-dimensional gel electrophoresis and probed using pooled antisera from 20 CBA/J mice chronically infected with E. coli CFT073. In total, 23 outer membrane antigens, including a novel iron compound receptor, reacted with the antisera and were identified by mass spectrometry. These antigens also included proteins with known roles in UPEC pathogenesis, such as ChuA, IroN, IreA, Iha, IutA, and FliC. These data demonstrate that an antibody response is directed against these virulence-associated factors during UTI. We also show that the genes encoding ChuA, IroN, hypothetical protein c2482, and IutA are significantly more prevalent (P < 0.01) among UPEC strains than among fecal-commensal E. coli isolates. Thus, we suggest that the conserved outer membrane antigens identified in this study could be rational candidates for a UTI vaccine designed to elicit protective immunity against UPEC infection.

MeSH Terms
Animals Antigens, Bacterial/biosynthesis,immunology Bacterial Outer Membrane Proteins/biosynthesis,immunology Blotting, Western Disease Models, Animal Electrophoresis, Gel, Two-Dimensional Escherichia coli/immunology,physiology Escherichia coli Infections/immunology,microbiology Escherichia coli Proteins/biosynthesis,immunology Female Gene Expression Regulation, Bacterial Humans Mass Spectrometry Mice Mice, Inbred CBA Proteome/analysis Urinary Tract Infections/immunology,microbiology Virulence Factors/biosynthesis,immunology
Chemicals
Antigens, Bacterial Bacterial Outer Membrane Proteins Escherichia coli Proteins Proteome Virulence Factors
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hagan Erin C
Department of Microbiology and Immunology, University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, MI 48109, USA.
Mobley Harry L T
References (53)
53 references, click to expand
  1. Proteomic analysis of the Escherichia coli outer membrane.
    Eur J Biochem. 2000 May;267(10):2871-81 PMID: 10806384
  2. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
    Science. 2000 Mar 10;287(5459):1816-20 PMID: 10710308
  3. Transcriptome of uropathogenic Escherichia coli during urinary tract infection.
    Infect Immun. 2004 Nov;72(11):6373-81 PMID: 15501767
  4. Genetic and metabolic control of enzymes responsible for histidine degradation in Salmonella typhimurium. 4-imidazolone-5-propionate amidohydrolase and N-formimino-L-glutamate formiminohydrolase.
    J Biol Chem. 1971 May 25;246(10):3320-9 PMID: 4930059
  5. Haemolysin contributes to virulence of extra-intestinal E. coli infections.
    Nature. 1981 Dec 17;294(5842):665-7 PMID: 7031483
  6. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
    Infect Immun. 1983 Apr;40(1):273-83 PMID: 6339403
  7. Purification of the Escherichia coli type 1 pilin and minor pilus proteins and partial characterization of the adhesin protein.
    J Bacteriol. 1988 Aug;170(8):3350-8 PMID: 2900235
  8. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
    Infect Immun. 1990 May;58(5):1281-9 PMID: 2182540
  9. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.
    Infect Immun. 1991 Mar;59(3):1153-61 PMID: 1671776
  10. Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women.
    J Infect Dis. 1991 Apr;163(4):773-9 PMID: 1672702
  11. Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection.
    J Urol. 1993 Apr;149(4):922-5 PMID: 8455276
  12. The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract.
    Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11889-93 PMID: 7991552
  13. Resolution time of Escherichia coli cystitis is correlated with levels of preinfection antibody to the infecting Escherichia coli strain.
    Urology. 1995 Jan;45(1):42-6 PMID: 7817479
  14. Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection.
    J Infect Dis. 1995 Jun;171(6):1514-21 PMID: 7769286
  15. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9827-32 PMID: 8790416
  16. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.
    J Clin Invest. 1997 Apr 1;99(7):1662-72 PMID: 9120010
  17. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Science. 1997 Apr 25;276(5312):607-11 PMID: 9110982
  18. Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice.
    Infect Immun. 1998 Jul;66(7):3059-65 PMID: 9632566
  19. Structure of the outer membrane protein A transmembrane domain.
    Nat Struct Biol. 1998 Nov;5(11):1013-7 PMID: 9808047
  20. Neutrophil recruitment and resistance to urinary tract infection.
    J Infect Dis. 1999 Oct;180(4):1220-9 PMID: 10479151
  21. Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.
    Infect Immun. 2005 Jan;73(1):627-31 PMID: 15618205
  22. The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection.
    Infect Immun. 2005 Feb;73(2):965-71 PMID: 15664939
  23. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    J Infect Chemother. 2005 Feb;11(1):44-7 PMID: 15729488
  24. Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation.
    Microbiology. 2005 May;151(Pt 5):1313-23 PMID: 15870442
  25. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.
    Infect Immun. 2005 Nov;73(11):7644-56 PMID: 16239569
  26. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.
    Infect Immun. 2005 Dec;73(12):8109-18 PMID: 16299305
  27. Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis.
    Proteomics. 2006 Feb;6(3):836-44 PMID: 16372264
  28. Antigen-specific responses accelerate bacterial clearance in the bladder.
    J Immunol. 2006 Mar 1;176(5):3080-6 PMID: 16493067
  29. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.
    Nat Med. 2006 Jun;12(6):636-41 PMID: 16751768
  30. A universal vaccine for serogroup B meningococcus.
    Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9 PMID: 16825336
  31. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.
    Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12879-84 PMID: 16912116
  32. Novel surface polypeptides of Campylobacter jejuni as traveller's diarrhoea vaccine candidates discovered by proteomics.
    Vaccine. 2006 Sep 29;24(40-41):6446-55 PMID: 16824653
  33. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.
    Infect Immun. 2007 Apr;75(4):1916-25 PMID: 17145948
  34. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    J Urol. 2007 Apr;177(4):1349-53; quiz 1591 PMID: 17382730
  35. Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine.
    Infect Immun. 2007 Jun;75(6):2679-88 PMID: 17513849
  36. Urinary tract infection: self-reported incidence and associated costs.
    Ann Epidemiol. 2000 Nov;10(8):509-15 PMID: 11118930
  37. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
    J Immunol. 2001 Jan 15;166(2):1148-55 PMID: 11145696
  38. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.
    Infect Immun. 2001 Jun;69(6):3954-64 PMID: 11349064
  39. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
    Ann Intern Med. 2001 Jul 3;135(1):41-50 PMID: 11434731
  40. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse.
    Infect Immun. 2001 Oct;69(10):6179-85 PMID: 11553558
  41. Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli.
    Infect Immun. 2001 Oct;69(10):6209-16 PMID: 11553562
  42. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract.
    Mol Microbiol. 2002 Aug;45(4):1079-93 PMID: 12180926
  43. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.
    Infect Immun. 2002 Dec;70(12):7156-60 PMID: 12438401
  44. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4203-8 PMID: 12655047
  45. The outer membrane protein X from Escherichia coli exhibits immune properties.
    Vaccine. 2003 Sep 8;21(25-26):3765-74 PMID: 12922110
  46. The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.
    Infect Immun. 2003 Dec;71(12):7164-9 PMID: 14638809
  47. A toll-like receptor that prevents infection by uropathogenic bacteria.
    Science. 2004 Mar 5;303(5663):1522-6 PMID: 15001781
  48. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    J Urol. 2004 Apr;171(4):1682-5 PMID: 15017266
  49. Predominant outer membrane antigens of Bartonella henselae.
    Infect Immun. 2004 Jun;72(6):3097-105 PMID: 15155610
  50. A novel lipolytic enzyme located in the outer membrane of Pseudomonas aeruginosa.
    J Bacteriol. 1999 Nov;181(22):6977-86 PMID: 10559163
  51. The urinary tract response to entry of pathogens.
    World J Urol. 1999 Dec;17(6):351-8 PMID: 10654365
  52. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    J Infect Dis. 2000 Feb;181(2):774-8 PMID: 10669375
  53. Identification of sat, an autotransporter toxin produced by uropathogenic Escherichia coli.
    Mol Microbiol. 2000 Oct;38(1):53-66 PMID: 11029690
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2007-08-00
Epub
2007-00-21
Pages
3941-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC1951972
Subset
IM
Grants
NIAID NIH HHS · AI 059722 · United States
NIAID NIH HHS · R01 AI059722 · United States
NIAID NIH HHS · R56 AI043363 · United States
NIAID NIH HHS · R01 AI043363 · United States
NIAID NIH HHS · AI 43363 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com